Allogene Therapeutics
ALLO
ALLO
177 hedge funds and large institutions have $1.28B invested in Allogene Therapeutics in 2021 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 68 increasing their positions, 42 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.66% less ownership
Funds ownership: 61.87% → 60.21% (-1.7%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
43% less capital invested
Capital invested by funds: $2.26B → $1.28B (-$981M)
Holders
177
Holding in Top 10
3
Calls
$2.29M
Puts
$2.02M
Top Buyers
| 1 | +$30.8M | |
| 2 | +$15.8M | |
| 3 | +$14.4M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$14.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$13.4M |
Top Sellers
| 1 | -$139M | |
| 2 | -$46.6M | |
| 3 | -$29.2M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$19.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.2M |